title: Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?
abstract: More than 1.4 million patients are on renal replacement therapy worldwide. Mortality in patients with end-stage renal disease (ESRD) is as high as that seen in some types of metastatic cancer, and premature cardiovascular disease is the major killer in ESRD. Several publications in 2011 addressed how interventions can modify cardiovascular risk factors and improve outcomes.
authors.affiliation: Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital at Huddinge, Karolinska Institutet, SE 141 86 Stockholm, Sweden. peter.stenvinkel@ki.se
authors.forename: Peter
authors.initials: P
authors.lastname: Stenvinkel
authors.forename: Peter
authors.initials: P
authors.lastname: Bárány
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D015897:Comorbidity; D014943:Global Health; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D011379:Prognosis; D006435:Renal Dialysis; D012307:Risk Factors